Heterogeneity in intratumor correlations of 18F-FDG, 18F-FLT, and 61Cu-ATSM PET in canine sinonasal tumors. - Test2 - elhamkhani - TriplyDB

Heterogeneity in intratumor correlations of 18F-FDG, 18F-FLT, and 61Cu-ATSM PET in canine sinonasal tumors.

Heterogeneity in intratumor correlations of 18F-FDG, 18F-FLT, and 61Cu-ATSM PET in canine sinonasal tumors.

http://www.wikidata.org/entity/Q38424458

about

Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).Micro Regional Heterogeneity of 64Cu-ATSM and 18F-FDG Uptake in Canine Soft Tissue Sarcomas: Relation to Cell Proliferation, Hypoxia and Glycolysis.Use of Molecular Imaging Markers of Glycolysis, Hypoxia and Proliferation ((18)F-FDG, (64)Cu-ATSM and (18)F-FLT) in a Dog with Fibrosarcoma: The Importance of Individualized Treatment Planning and Monitoring.Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.An alternative approach to histopathological validation of PET imaging for radiation therapy image-guidance: a proof of concept Defining the Value of a Comparative Approach to Cancer Drug Development.Cancer and comparative imaging.A Novel Framework for Automated Segmentation and Labeling of Homogeneous Versus Heterogeneous Lung Tumors in [18F]FDG-PET Imaging.Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study.Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.INVITED REVIEW--IMAGE REGISTRATION IN VETERINARY RADIATION ONCOLOGY: INDICATIONS, IMPLICATIONS, AND FUTURE ADVANCES.The promise of multiparametric imaging in oncology: how do we move forward?Sensitivity study of voxel-based PET image comparison to image registration algorithms.

P2860

Q35116540-A88A5D20-1251-4E4E-8A4B-4AC96C0386F5 Q35821298-2E7C145E-D01A-4CB3-BEAD-FB97E63CD607 Q36335296-70E8F3AA-8D7D-477D-BCC8-3060CD5F3E1F Q36427037-FA354386-B2B6-489C-81DB-2C6564FD5C55 Q36885338-AC233D2A-C478-4B51-A105-B9957B063E96 Q37417714-3B647700-421F-481A-A939-ED596EDB85FD Q38220808-816CDB84-A281-49D3-8CDE-F29C4B6034FD Q38405052-CA0A24B7-C82B-4DA8-8428-CC31806679EF Q38415240-27B5D448-50F3-423F-9AC8-2EC4BD20CDCA Q38421393-95F733C8-80D2-4EE3-828A-7FB8E390CABB Q38699968-F9DDA4AE-F551-4D68-8137-F9223F97B6DE Q50525080-14554801-EFD3-4371-AEAE-5725AFC678CE Q51016625-2CD06C7B-175F-47D3-A27A-34610FE22B6E

P2860

Heterogeneity in intratumor correlations of 18F-FDG, 18F-FLT, and 61Cu-ATSM PET in canine sinonasal tumors.

http://www.wikidata.org/entity/Q38424458

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Heterogeneity in intratumor co ...... ET in canine sinonasal tumors.

@en

type

label

Heterogeneity in intratumor co ...... ET in canine sinonasal tumors.

@en

prefLabel

Heterogeneity in intratumor co ...... ET in canine sinonasal tumors.

@en

P1433

Q38424458-C72E2D09-6E17-4E6F-88F6-04B44B21A292

P1476

Q38424458-26E86670-AE51-4771-AC45-1B03C6493007

P2093

Q38424458-27C7788A-B33C-4E95-A78D-7B5D7003E47D

Q38424458-5A8FCFFF-6924-46FB-9CB3-5C2AF1DC5AC9

Q38424458-867C7230-1526-4ADD-BD03-D8D5653317ED

Q38424458-B4ADA5C0-9890-40EE-B438-0FD3A1C3397F

Q38424458-F4E24F7D-8E24-4991-9FEE-95D8C77FD32B

P2860

Q38424458-079034EC-E6F8-4415-AF12-9622CDD48CC0

Q38424458-13D6D464-0E7A-49D9-89D1-AC8AC255E9D6

Q38424458-35103883-DCBD-4B2C-84F1-0FA335321ABD

Q38424458-4CC1E7F7-1A83-435E-A166-E19BB9B2D590

Q38424458-55991476-C6F4-4FF6-8529-C300DEBE7CA9

Q38424458-6930C2C6-7209-488E-B7B5-0049325589D9

Q38424458-7A7DF88C-8994-4D8A-9CFF-24711ADE1B2D

Q38424458-834AA579-BA4D-43BA-BF22-EB867EE07255

Q38424458-83B7EEC3-D843-408C-9473-954C944C9D36

Q38424458-87BE6F4A-E815-4BE4-9B9E-2DD5ACC9EFC0

P304

Q38424458-95F578AF-3BC9-4968-89DE-5AEAC89C5624

P31

Q38424458-1DCC74F1-2105-47A3-A9BA-330770F1CE7D

P356

Q38424458-A41168A8-7428-441A-B7DC-8C01B5DF4C8E

P407

Q38424458-6D091030-B2F1-40C8-9CF7-77BD2F66D60D

P433

Q38424458-3F11287F-646D-446F-8F40-5E7AB8EA4129

P478

Q38424458-1C1D1550-B833-433E-A232-45DCCFB919F3

P577

Q38424458-D1D269CB-684B-452A-ACDA-728E8402CF0F

P5875

Q38424458-3979C385-80C2-441B-8B27-CABC0ED98BF2

P698

Q38424458-3A4BE82C-F504-4A30-8357-9496928550F9

P932

Q38424458-6B904A5D-4DFA-4927-9AF7-FA68478FF59B

P356

JNUMED.113.121921

P1433

The Journal of Nuclear Medicine

P1476

Heterogeneity in intratumor co ...... ET in canine sinonasal tumors.

@en

P2093

Lisa J Forrest

http://www.w3.org/2001/XMLSchema#string

Ngoneh Jallow

http://www.w3.org/2001/XMLSchema#string

Robert Jeraj

http://www.w3.org/2001/XMLSchema#string

Stephen R Bowen

http://www.w3.org/2001/XMLSchema#string

Tyler J Bradshaw

http://www.w3.org/2001/XMLSchema#string

P2860

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.

Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.

PET imaging for the quantification of biologically heterogeneous tumours: measuring the effect of relative position on image-based quantification of dose-painting targets.

Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.

Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy

The clinical approach towards chondrosarcoma.

An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperII.

P304

1931-1937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.113.121921

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256664887

http://www.w3.org/2001/XMLSchema#string

P698

24042031

http://www.w3.org/2001/XMLSchema#string

P932

3974156

http://www.w3.org/2001/XMLSchema#string